Author:
Garcia-Garcia Guillermo,Tonelli Marcello,Ibarra-Hernandez Margarita,Chavez-Iñiguez Jonathan S.,Oseguera-Vizcaino Ma. Concepcion
Abstract
Abstract
Background
Access to kidney transplantation is limited to more than half of the Mexican population.
A fragmented health system, gender, and sociocultural factors are barriers to transplant care. We analyzed kidney transplantation in Mexico and describe how public policies and sociocultural factors result in these inequities.
Methods
Kidney transplant data between 2007 to 2019 were obtained from the National Transplant Center database. Transplant rates and time spent on the waiting list, by age, gender, health system, and insurance status, were estimated.
Results
During the study period 34,931 transplants were performed. Recipients median age was 29 (IQR 22–42) years, 62.4% were males, and 73.9% were insured. 72.7% transplants were from living-donors. Annual transplant rates increased from 18.9 per million population (pmp) to 23.3 pmp. However, the transplant rate among the uninsured population remained low, at 9.3 transplants pmp. In 2019, 15,890 patients were in the waiting list; 60.6% were males and 88% were insured. Waiting time to transplant was 1.55 (IQR 0.56–3.14) years and it was shorter for patients listed in the Ministry of Health and private facilities, where wait lists are smaller, and for males. Deceased-organ donation rates increased modestly from 2.5 pmp to 3.9 pmp.
Conclusions
In conclusion, access to kidney transplantation in Mexico is unequal and restricted to patients with medical insurance. An inefficient organ procurement program results in low rates of deceased-donor kidneys. The implementation of a comprehensive kidney care program, recognizing kidney transplantation as the therapy of choice for renal failure, offers an opportunity to correct these inequalities.
Publisher
Springer Science and Business Media LLC
Reference35 articles.
1. Tonelli M, Wiebe N, Knoll G, Bello A, Browne S, Jadhav D, et al. Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes. Am J Transplant. 2011;11(10):2093–109.
2. Harris DCH, Davies SJ, Finkelstein FO, Jha V, Donner JA, Abraham G, et al. Increasing access to integrated ESKD care as part of universal health coverage. Kidney Int. 2019;95(4S):S1–S33.
3. Dominguez Garcia Villalobos J. Algunos aspectos jurídicos de los trasplantes de órganos. 1st. ed. Mexico City: Editorial Porrúa, S.A; 1993.
4. Garcia-Garcia G, Garcia-Bejarano H, Breien-Coronado H, Perez-Cortes G, Pazarin-Villaseñor L, De la Torre-Campos L, et al. End-stage renal disease in Mexico. In: Garcia-Garcia G, Agodoa L, Norris K, editors. Chronic kidney disease in disadvantaged populations. New York: Elsevier; 2017. p. 77–82.
5. Dib-Kuri A, Aburto-Morales S, Espinosa-Alvarez A, Sánchez-Ramírez O. Organ and tissue transplants in Mexico. Rev Investig Clin. 2005;57(2):163–9.
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献